Literature DB >> 3364151

Half-life of plasma cholinesterase.

D Ostergaard1, J Viby-Mogensen, H K Hanel, L T Skovgaard.   

Abstract

The half-life of plasma cholinesterase (acylcholine acylhydrolase EC 3.1.1.8) was determined in three patients homozygous for the atypical gene for plasma cholinesterase by measuring the rate of disappearance of enzyme activity following intravenous injection of concentrated human cholinesterase. Half-life values of 10.9, 11.1, and 11.3 days were estimated. The distribution volume was estimated to be 18.0, 18.2, and 13.8% of body weight, respectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3364151     DOI: 10.1111/j.1399-6576.1988.tb02727.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  34 in total

Review 1.  Cocaine hydrolase gene therapy for cocaine abuse.

Authors:  Stephen Brimijoin; Yang Gao
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

2.  Identification of phosphorylated butyrylcholinesterase in human plasma using immunoaffinity purification and mass spectrometry.

Authors:  Uma K Aryal; Chiann-Tso Lin; Jong-Seo Kim; Tyler H Heibeck; Jun Wang; Wei-Jun Qian; Yuehe Lin
Journal:  Anal Chim Acta       Date:  2012-02-19       Impact factor: 6.558

Review 3.  Protein adducts as biomarkers of exposure to organophosphorus compounds.

Authors:  Judit Marsillach; Lucio G Costa; Clement E Furlong
Journal:  Toxicology       Date:  2012-12-20       Impact factor: 4.221

Review 4.  Acetylcholinesterase inhibition resulting from exposure to inhaled OP can be prevented by pretreatment with BChE in both macaques and minipigs.

Authors:  Yvonne Rosenberg; Ashima Saxena
Journal:  Neuropharmacology       Date:  2020-05-19       Impact factor: 5.250

5.  Biomarkers of organophosphorus (OP) exposures in humans.

Authors:  Judit Marsillach; Rebecca J Richter; Jerry H Kim; Richard C Stevens; Michael J MacCoss; Daniela Tomazela; Stephanie M Suzuki; Lawrence M Schopfer; Oksana Lockridge; Clement E Furlong
Journal:  Neurotoxicology       Date:  2011-07-08       Impact factor: 4.294

6.  Crystallization and X-ray structure of full-length recombinant human butyrylcholinesterase.

Authors:  Michelle N Ngamelue; Kohei Homma; Oksana Lockridge; Oluwatoyin A Asojo
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-08-10

7.  Longitudinal assessment of chlorpyrifos exposure and effect biomarkers in adolescent Egyptian agricultural workers.

Authors:  Alice L Crane; Gaafar Abdel Rasoul; Ahmed A Ismail; Olfat Hendy; Matthew R Bonner; Michael R Lasarev; Manal Al-Batanony; Steven T Singleton; Khalid Khan; James R Olson; Diane S Rohlman
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-01-16       Impact factor: 5.563

8.  Characterization of butyrylcholinesterase from porcine milk.

Authors:  Ashima Saxena; Tatyana Belinskaya; Lawrence M Schopfer; Oksana Lockridge
Journal:  Arch Biochem Biophys       Date:  2018-06-15       Impact factor: 4.013

9.  The proline-rich tetramerization peptides in equine serum butyrylcholinesterase.

Authors:  Kevser Biberoglu; Lawrence M Schopfer; Ozden Tacal; Oksana Lockridge
Journal:  FEBS J       Date:  2012-09-07       Impact factor: 5.542

10.  Pseudocholinesterase enzyme deficiency: a case series and review of the literature.

Authors:  Beyazit Zencirci
Journal:  Cases J       Date:  2009-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.